Cognetivity Neurosciences (CSE: CGN) this morning announced that it has added a former UK Health Minister to its advisory board. The appointment will see Lord O’Shaughnessy to the firms advisory board, effective immediately.
A member of the UK House of Lords, which is an upper house of the parliament within the United Kingdom, O’Shaughnessy comes highly experienced in the field of healthcare. Previously, he served as parliamentary under-secretary of state at the Department of Health, while also serving as the lead for the Medicines and Healthcare products Regulatory Agency, or MHRA.
Outside of his involvement in healthcare, James O’Shaughnessy has also served as a director of polcy to Prime Minister David Cameron and is currently a visiting professor for the Institute of Global Health Innovation at Imperial College London. Within healthcare, he currently serves as an advisor or director at a number of firms including Health Data Research UK, Healthy.io, Push Doctor, Bain & Company, and a number of healthcare related ventures.
“There’s no doubt that the future of healthcare looks increasingly digital – there are enormous improvements in patient outcomes to be made through the use of innovative technology. I greatly look forward to working with the team to ensure Cognetivity’s technology is able to improve the lives of as many people as possible.”
Lord O’Shaughnessy
Cognetivity Neurosciences last traded at $0.58 on the CSE.
Sponsored · PTX Metals Inc.
FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
